Lily Chai is a seasoned compliance professional currently serving as China Compliance Lead at 安进 since 2022. Previously, they were the Compliance Director at 和黄医药 from 2020 to 2022, where they established a compliance function and led a team to support business growth. Prior roles include Associate Director and Compliance Officer for the Hypertension and Cardio-Metabolic business units at 诺华, and Senior Accountant at Aon-COFCO Insurance Brokers Co., Ltd from 2006 to 2011. Lily Chai holds an MBA from China Europe International Business School and participated in an exchange program at the University of Michigan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices